Dubuis Hospital For Continuing Care is categorized under Hospitals in Texarkana, TX and active since 1997.
Dubuis Hospital For Continuing Care was established in 1997, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 622110 by the NAICS.
If you are seeking more information, feel free to contact Carlotta Temple at the company’s single location by writing to 2604 Saint Michael Drive, Texarkana, Texas TX 75503 or by phoning (903) 614-7600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Dubuis Hospital For Continuing Care |
Contact Person: | Carlotta Temple |
Address: | 2604 Saint Michael Drive, Texarkana, Texas 75503 |
Phone Number: | (903) 614-7600 |
Website Address: | dubuis.org |
Annual Revenue (USD): | $5.000.000 to $9.999.999 |
Founded: | 1997 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Hospitals |
SIC Code: | 8062 |
NAICS Code: | 622110 |
Share This Business: |
Dubuis Hospital For Continuing Care was started in 1997 to provide professional Hospitals under the SIC code 8062 and NAICS code 622110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Carlotta Temple for inquiries that concern Dubuis Hospital For Continuing Care by calling the company number (903) 614-7600, as your correspondence is most welcome. Additionally, the physical location of the single location of Dubuis Hospital For Continuing Care can be found at the coordinates 33.4623,-94.075661 as well as the street address 2604 Saint Michael Drive in Texarkana, Texas 75503.
For its online presence, you may visit Dubuis Hospital For Continuing Care’s website at dubuis.org and engage with its social media outlets through on Twitter and on Facebook.